A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources episode artwork

EPISODE · Oct 18, 2016 · 9 MIN

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

from Clinical Chemistry Podcast

Measurement of serum cancer antigen 125 (CA125) is the standard approach for epithelial ovarian cancer (EOC) diagnostics and follow-up. However, the clinical specificity is not optimal because increased values are also detected in healthy controls and in benign diseases.

Episode metadata supplied by the publisher feed · Published Oct 18, 2016

Embed this episode

NOW PLAYING

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

0:00 9:33

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinical Chemistry Podcast?

This episode is 9 minutes long.

When was this Clinical Chemistry Podcast episode published?

This episode was published on October 18, 2016.

Can I download this Clinical Chemistry Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!